001     885450
005     20210130010410.0
024 7 _ |a 10.1016/j.jbiotec.2020.09.016
|2 doi
024 7 _ |a 0168-1656
|2 ISSN
024 7 _ |a 1873-4863
|2 ISSN
024 7 _ |a 2128/26006
|2 Handle
024 7 _ |a 32976868
|2 pmid
024 7 _ |a WOS:000600955400007
|2 WOS
037 _ _ |a FZJ-2020-03833
082 _ _ |a 540
100 1 _ |a Muschallik, Lukas
|0 P:(DE-Juel1)157953
|b 0
245 _ _ |a Synthesis of α-hydroxy ketones and vicinal diols with the Bacillus licheniformis DSM 13T butane-2,3-diol dehydrogenase
260 _ _ |a Amsterdam [u.a.]
|c 2020
|b Elsevier Science
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1604299814_23528
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The enantioselective synthesis of α-hydroxy ketones and vicinal diols is an intriguing field because of the broad applicability of these molecules. Although, butandiol dehydrogenases are known to play a key role in the production of 2,3-butandiol, their potential as biocatalysts is still not well studied. Here, we investigate the biocatalytic properties of the meso-butanediol dehydrogenase from Bacillus licheniformis DSM 13T (BlBDH). The encoding gene was cloned with an N-terminal StrepII-tag and recombinantly overexpressed in E. coli. BlBDH is highly active towards several non-physiological diketones and α-hydroxyketones with varying aliphatic chain lengths or even containing phenyl moieties. By adjusting the reaction parameters in biotransformations the formation of either the α-hydroxyketone intermediate or the diol can be controlled.
536 _ _ |a 581 - Biotechnology (POF3-581)
|0 G:(DE-HGF)POF3-581
|c POF3-581
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Kipp, Carina Ronja
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Recker, Inga
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Bongaerts, Johannes
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Pohl, Martina
|0 P:(DE-Juel1)131522
|b 4
700 1 _ |a Gellissen, Melanie
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Schöning, Michael J.
|0 P:(DE-Juel1)128727
|b 6
700 1 _ |a Selmer, Thorsten
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Siegert, Petra
|0 P:(DE-HGF)0
|b 8
|e Corresponding author
773 _ _ |a 10.1016/j.jbiotec.2020.09.016
|g Vol. 324, p. 61 - 70
|0 PERI:(DE-600)2016476-2
|p 61 - 70
|t Journal of biotechnology
|v 324
|y 2020
|x 0168-1656
856 4 _ |y Published on 2020-09-22. Available in OpenAccess from 2021-09-22.
|u https://juser.fz-juelich.de/record/885450/files/Muschallik%20et%20all%20JBIOTEC-S-20-01483.pdf
856 4 _ |y Published on 2020-09-22. Available in OpenAccess from 2021-09-22.
|x pdfa
|u https://juser.fz-juelich.de/record/885450/files/Muschallik%20et%20all%20JBIOTEC-S-20-01483.pdf?subformat=pdfa
909 C O |o oai:juser.fz-juelich.de:885450
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)157953
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)131522
913 1 _ |a DE-HGF
|b Key Technologies
|l Key Technologies for the Bioeconomy
|1 G:(DE-HGF)POF3-580
|0 G:(DE-HGF)POF3-581
|2 G:(DE-HGF)POF3-500
|v Biotechnology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2020
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2019-12-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2019-12-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2019-12-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2019-12-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2019-12-21
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
915 _ _ |a Embargoed OpenAccess
|0 StatID:(DE-HGF)0530
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
|d 2019-12-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2019-12-21
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
|d 2019-12-21
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
|d 2019-12-21
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2019-12-21
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2019-12-21
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J BIOTECHNOL : 2018
|d 2019-12-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
|d 2019-12-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2019-12-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2019-12-21
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2019-12-21
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2019-12-21
920 1 _ |0 I:(DE-Juel1)IBG-1-20101118
|k IBG-1
|l Biotechnologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)IBG-1-20101118
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21